Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB PEGOL vs CEVIMELINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERTOLIZUMAB PEGOL vs CEVIMELINE: Safety Overview

Metric CERTOLIZUMAB PEGOL CEVIMELINE
Total FAERS Reports 99,098 224
Deaths Reported 5,361 0
Death Rate 5.4% N/A
Hospitalizations 17,641 26
Average Patient Age 49.5 yrs 60.7 yrs
% Female Patients 83.1% 85.9%
FDA Approval Date N/A Apr 18, 2023
Manufacturer UCB, Inc. Macleods Pharmaceuticals Limited
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription